Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Rapid Transformation to Aggressive B-Cell Lymphoma, in a Case of Mixed Cellularity Hodgkin Lymphoma Subtype : A Rare Event

Antonio Abbadessa, Salvatore Iaccarino, Giuseppe Monaco, Maria Luigia Vigliotti, Mario Troiano, Enrico Attingenti

Blood (2008) 112 (11): 4831.

https://doi.org/10.1182/blood.V112.11.4831.4831

Published: 2008

Journal Articles

Long Term Disease Free Survival in Patient with Linfoplasmocytic Lymphoma and Regression of Associated Severe Renal Failure after Treatment with Bortezomib.

Antonio Abbadessa, Giuseppe Monaco, Mario Troiano, Lucia Liguori, Elisa Focarile, Maria Luigia Vigliotti, Salvatore Iaccarino

Blood (2007) 110 (11): 4477.

https://doi.org/10.1182/blood.V110.11.4477.4477

Published: 2007

Journal Articles

Non-Hodgkin Lymphoma Involving the Bone (NHLB): Report of Ten Cases.

Maria Luigia Vigliotti, MD, Flavio Fazioli, MD, Anna De Chiara, MD, Giovanni D’Arena, MD, Oreste Villani, MD, Antonio Pinto, MD

Blood (2006) 108 (11): 4660.

https://doi.org/10.1182/blood.V108.11.4660.4660

Published: 2006

Journal Articles

Intensity of 18 Fluorodeoxyglucose Uptake in Positron Emission Tomography Is Associated with Unfavorable Prognostic Factors in Untreated Follicular Lymphoma.

Maria Luigia Vigliotti, MD, Giuseppe Cascini, MD, Ferdinando Frigeri, MD, Anna De Chiara, MD, Paola Della Cioppa, MD, Filomena Oliviero, MD, Secondo Lastoria, MD, Antonio Pinto, MD

Blood (2005) 106 (11): 1001.

https://doi.org/10.1182/blood.V106.11.1001.1001

Published: 2005

Journal Articles

High-Dose of Epoietin Alfa in Patients with Low-Risk Myelodysplastic Syndromes (MDS): A Single Institution Experience.

Giuseppe Mele, MD, Clelia Musto, MD, Rosella Matera, PhD, Maria Luigia Vigliotti, MD, Alfredo Tartarone, MD, Giampiero Romano, MD, Mariarosa Coccaro, MD, Nicola Di Renzo, MD

Blood (2004) 104 (11): 4703.

https://doi.org/10.1182/blood.V104.11.4703.4703

Published: 2004

Journal Articles

CD38 expression does not change in B-cell chronic lymphocytic leukemia

Giovanni D'Arena, Giuseppe Nunziata, Giuseppe Coppola, Maria Luigia Vigliotti, Alfredo Tartarone, Nicola Carpinelli, Rosella Matera, Rosario Colella Bisogno, Giuseppe Pistolese, Nicola Di Renzo

Blood (2002) 100 (8): 3052.

https://doi.org/10.1182/blood-2002-07-2249

Published: 2002

NARROW

Rapid Transformation to Aggressive B-Cell Lymphoma, in a Case of Mixed Cellularity Hodgkin Lymphoma Subtype : A Rare Event

Long Term Disease Free Survival in Patient with Linfoplasmocytic Lymphoma and Regression of Associated Severe Renal Failure after Treatment with Bortezomib.

Non-Hodgkin Lymphoma Involving the Bone (NHLB): Report of Ten Cases.

Intensity of 18 Fluorodeoxyglucose Uptake in Positron Emission Tomography Is Associated with Unfavorable Prognostic Factors in Untreated Follicular Lymphoma.

High-Dose of Epoietin Alfa in Patients with Low-Risk Myelodysplastic Syndromes (MDS): A Single Institution Experience.

CD38 expression does not change in B-cell chronic lymphocytic leukemia

Email alerts

ASH Publications

American Society of Hematology

Rapid Transformation to Aggressive B-Cell Lymphoma, in a Case of Mixed Cellularity Hodgkin Lymphoma Subtype : A Rare Event

Long Term Disease Free Survival in Patient with Linfoplasmocytic Lymphoma and Regression of Associated Severe Renal Failure after Treatment with Bortezomib.

Non-Hodgkin Lymphoma Involving the Bone (NHLB): Report of Ten Cases.

Intensity of 18 Fluorodeoxyglucose Uptake in Positron Emission Tomography Is Associated with Unfavorable Prognostic Factors in Untreated Follicular Lymphoma.

High-Dose of Epoietin Alfa in Patients with Low-Risk Myelodysplastic Syndromes (MDS): A Single Institution Experience.

CD38 expression does not change in B-cell chronic lymphocytic leukemia

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only